BACKGROUND: Chronic cocaine use may lead to premature atherosclerosis, however, the prevalence of and risk factors for coronary artery disease in asymptomatic cocaine users have not been reported. METHODS: Between August 2007 and June 2010, 385 African American chronic cocaine users aged 25 to 54 years were consecutively enrolled in a study to investigate the prevalence of CT angiographically-defined significant (≥ 50%) coronary stenosis and related risk factors. Sociodemographic, drug-use behavior, medical history and medication data were obtained by interview and confirmed by medical chart review. Clinical examinations were performed as well as extensive laboratory tests including those for fasting lipid profiles, HIV, high sensitivity C-reactive protein, and vitamin D. Contrast-enhanced coronary CT angiography was performed. RESULTS: Significant coronary stenosis was detected in 52 of 385 participants (13.5%). The prevalences were 12% and 30% in those with low risk and with middle-high risk Framingham score, respectively. In those with low risk scores, the prevalences of significant stenosis were 10% and 18% in those without and with vitamin D deficiency, defined as serum 25-(OH) vitamin D< 10 ng/mL (p=0.08). Multiple logistic regression analysis revealed that vitamin D deficiency (adjusted OR=2.18, 95% CI: 1.07-4.43) is independently associated with the presence of significant coronary stenosis after controlling for traditional risk factors. CONCLUSIONS: The study indicates that the prevalence of significant coronary stenoses is high in asymptomatic young and middle-aged African American chronic cocaine users. These findings emphasize the importance of aggressive reduction of risk factors, including vitamin D deficiency in this population.
BACKGROUND: Chronic cocaine use may lead to premature atherosclerosis, however, the prevalence of and risk factors for coronary artery disease in asymptomatic cocaine users have not been reported. METHODS: Between August 2007 and June 2010, 385 African American chronic cocaine users aged 25 to 54 years were consecutively enrolled in a study to investigate the prevalence of CT angiographically-defined significant (≥ 50%) coronary stenosis and related risk factors. Sociodemographic, drug-use behavior, medical history and medication data were obtained by interview and confirmed by medical chart review. Clinical examinations were performed as well as extensive laboratory tests including those for fasting lipid profiles, HIV, high sensitivity C-reactive protein, and vitamin D. Contrast-enhanced coronary CT angiography was performed. RESULTS: Significant coronary stenosis was detected in 52 of 385 participants (13.5%). The prevalences were 12% and 30% in those with low risk and with middle-high risk Framingham score, respectively. In those with low risk scores, the prevalences of significant stenosis were 10% and 18% in those without and with vitamin D deficiency, defined as serum 25-(OH) vitamin D< 10 ng/mL (p=0.08). Multiple logistic regression analysis revealed that vitamin D deficiency (adjusted OR=2.18, 95% CI: 1.07-4.43) is independently associated with the presence of significant coronary stenosis after controlling for traditional risk factors. CONCLUSIONS: The study indicates that the prevalence of significant coronary stenoses is high in asymptomatic young and middle-aged African American chronic cocaine users. These findings emphasize the importance of aggressive reduction of risk factors, including vitamin D deficiency in this population.
Authors: Shenghan Lai; Hong Lai; Qingyi Meng; Wenjing Tong; David Vlahov; David Celentano; Steffanie Strathdee; Kenrad Nelson; Elliot K Fishman; Joao A C Lima Journal: Am J Cardiol Date: 2002-08-01 Impact factor: 2.778
Authors: L T Clark; K C Ferdinand; J M Flack; J R Gavin; W D Hall; S K Kumanyika; J W Reed; E Saunders; H A Valantine; K Watson; N K Wenger; J T Wright Journal: Heart Dis Date: 2001 Mar-Apr
Authors: Shanna Nesby-O'Dell; Kelley S Scanlon; Mary E Cogswell; Cathleen Gillespie; Bruce W Hollis; Anne C Looker; Chris Allen; Cindy Doughertly; Elaine W Gunter; Barbara A Bowman Journal: Am J Clin Nutr Date: 2002-07 Impact factor: 7.045
Authors: Hong Lai; Gary Gerstenblith; Elliot K Fishman; Jeffrey Brinker; Thomas Kickler; Wenjing Tong; Sundeepan Bhatia; Tai Hong; Shaoguang Chen; Ji Li; Barbara Detrick; Shenghan Lai Journal: Clin Infect Dis Date: 2012-03-15 Impact factor: 9.079
Authors: Lediya T Cheru; Charles F Saylor; Kathleen V Fitch; Sara E Looby; Michael Lu; Udo Hoffmann; Takara L Stanley; Janet Lo Journal: Antivir Ther Date: 2019
Authors: Frances L Szeto; Catherine A Reardon; Dosuk Yoon; Youli Wang; Kari E Wong; Yunzi Chen; Juan Kong; Shu Q Liu; Ravi Thadhani; Godfrey S Getz; Yan Chun Li Journal: Mol Endocrinol Date: 2012-05-25
Authors: Hong Lai; Barbara Detrick; Elliot K Fishman; Gary Gerstenblith; Jeffrey A Brinker; Bruce W Hollis; John Bartlett; Joseph Cofrancesco; Wenjing Tong; Hong Tai; Shaoguang Chen; Sandeepan Bhatia; Shenghan Lai Journal: J Investig Med Date: 2012-06 Impact factor: 2.895
Authors: Shenghan Lai; Elliot K Fishman; Gary Gerstenblith; Jeffrey Brinker; Hong Tai; Shaoguang Chen; Ji Li; Wenjing Tong; Barbara Detrick; Hong Lai Journal: Vasc Health Risk Manag Date: 2013-08-26
Authors: Hong Lai; Elliot K Fishman; Gary Gerstenblith; Richard Moore; Jeffrey A Brinker; Jeanne C Keruly; Shaoguang Chen; Barbara Detrick; Shenghan Lai Journal: Vasc Health Risk Manag Date: 2013-11-15